1. Home
  2. TECH vs CRL Comparison

TECH vs CRL Comparison

Compare TECH & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

N/A

Current Price

$57.21

Market Cap

9.5B

Sector

Health Care

ML Signal

N/A

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

N/A

Current Price

$196.18

Market Cap

8.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TECH
CRL
Founded
1976
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
8.0B
IPO Year
1989
2000

Fundamental Metrics

Financial Performance
Metric
TECH
CRL
Price
$57.21
$196.18
Analyst Decision
Strong Buy
Buy
Analyst Count
14
14
Target Price
$71.23
$191.00
AVG Volume (30 Days)
1.8M
794.4K
Earning Date
02-04-2026
11-05-2025
Dividend Yield
0.56%
N/A
EPS Growth
N/A
N/A
EPS
0.49
N/A
Revenue
$1,216,732,000.00
$4,023,704,000.00
Revenue This Year
$2.33
N/A
Revenue Next Year
$7.05
$1.66
P/E Ratio
$117.08
N/A
Revenue Growth
3.85
N/A
52 Week Low
$46.01
$91.86
52 Week High
$79.28
$200.58

Technical Indicators

Market Signals
Indicator
TECH
CRL
Relative Strength Index (RSI) 38.12 67.00
Support Level $56.59 $194.50
Resistance Level $61.20 $200.58
Average True Range (ATR) 1.97 5.11
MACD -0.65 1.61
Stochastic Oscillator 4.84 84.13

Price Performance

Historical Comparison
TECH
CRL

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: